Inventor · disambiguated record
Lorenzo Leoni
Also filed as: LEONI LORENZO · LEONI LORENZO M
17 granted patents·20 pending applications·293 citations·filing 1998–2024
95Inventor score
Top patents by PatentIndex Score
37 records- 0188US7446122B2Substituted indole derivativesCEPHALON INC·Filed 2004·Granted Nov 4, 2008·29 cites·37 claims
- 0287US7361680B2Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2006·Granted Apr 22, 2008·12 cites·5 claims
- 0386US7682607B2Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomasUNIV CALIFORNIA·Filed 2002·Granted Mar 23, 2010·26 cites·6 claims
- 0486US7151100B1Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2000·Granted Dec 19, 2006·17 cites·13 claims
- 0585US7713526B2Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomasUNIV CALIFORNIA·Filed 2002·Granted May 11, 2010·28 cites·19 claims
- 0685US7129262B2Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2004·Granted Oct 31, 2006·15 cites·11 claims
- 0784US7314886B2Tetrahydropyrano-indole derivativesCEPHALON INC·Filed 2004·Granted Jan 1, 2008·25 cites·29 claims
- 0883US7211599B2Use of etodolac to treat hyperplasiaCEPHALON INC·Filed 2003·Granted May 1, 2007·15 cites·11 claims
- 0983US7189752B2Use of etodolac for the treatment of chronic lymphocytic leukemiaCARSON DENNIS A·Filed 2004·Granted Mar 13, 2007·14 cites·14 claims
- 1083US6696441B1Inhibition of p53-induced stress responseUNIV CALIFORNIA·Filed 2000·Granted Feb 24, 2004·13 cites·9 claims
- 1182US6545034B1Use of etodolac for the treatment of chronic lymphocytic leukemiaUNIV CALIFORNIA·Filed 1999·Granted Apr 8, 2003·52 cites·5 claims
- 1281US7105561B2Use of etodolac for the treatment of prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Sep 12, 2006·17 cites·8 claims
- 1375US7105560B1Use of etodolac in the treatment of multiple myelomaUNIV CALIFORNIA·Filed 2000·Granted Sep 12, 2006·14 cites·12 claims
- 1474US7157551B2Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancersCEPHALON INC·Filed 2004·Granted Jan 2, 2007·2 cites·5 claims
- 1568US6162810AInadone and tetralone compounds for inhibiting cell proliferationUNIV CALIFORNIA·Filed 1998·Granted Dec 19, 2000·13 cites·42 claims
- 1664US2007111950A1Indole compounds useful for the treatment of cancerCARSON DENNIS A·Filed 2006·Application pending·0 cites
- 1763US2024180910A1Method for treating cancer with a chemotherapeutic modifierELION ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1862US9066940B2Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationLEONI LORENZO·Filed 2010·Granted Jun 30, 2015·1 cites·13 claims
- 1962US2007299042A1Use of etodolac to treat hyperplasiaCARSON DENNIS A·Filed 2006·Application pending·0 cites
- 2060US2025017931A1Methods of personalizing cancer treatmentPROCESSA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2159US2005154010A1Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2256US9107919B2Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationTELORMEDIX SA·Filed 2013·Granted Aug 18, 2015·0 cites·15 claims
- 2356US2003216426A1Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogsUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 2454US2006040934A1Use of STAT-6 inhibitors as therapeutic agentsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 2553US2004096436A1Methods for inhibiting protein kinases in cancer cellsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2653US2017266297A1Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
- 2752US2009209606A1Cancer TreatmentsBENDALL HEATHER HELENE·Filed 2009·Application pending·0 cites
- 2851US2009202626A1Treatment of bladder diseases with a tlr7 activatorCARSON DENNIS A·Filed 2009·Application pending·0 cites
- 2949US2004127435A1Uses for inhibitors of inosine monophosphate dehydrogenaseUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 3048US2003232794A1Use of STAT-6 inhibitors as therapeutic agentsFiled 2003·Application pending·0 cites
- 3147US2016008477A1Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationTELORMEDIX SA·Filed 2015·Application pending·0 cites
- 3247US2003143199A1Use of STAT-6 inhibitors as therapeutic agentsFiled 2002·Application pending·0 cites
- 3346US2006041013A1Alanosine formulations and methods of useBRITTAIN JASON E·Filed 2005·Application pending·0 cites
- 3445US2004152672A1Indole compounds useful for the treatment of cancerFiled 2003·Application pending·0 cites
- 3543US2006128777A1Cancer treatmentsBENDALL HEATHER H·Filed 2005·Application pending·0 cites
- 3642US2003044409A1Immunologic compositions and methods for studying and treating cancers expressing frizzled antigensFiled 2001·Application pending·0 cites
- 3740US2002010125A1Assay for agents that induce chemokinesisFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →